Switzerland's Pharma M&A Landscape: Trends and Insights

This presentation delves into Switzerland's pharmaceutical M&A activity during 2019–2025, highlighting its global impact. It explores the nation's biotech and pharma innovation strength, dominance in M&A deals, and sector-specific dynamics. Detailed insights include transaction breakdowns, major players, and buyer strategies, with key examples like Pfizer's acquisition of Therachon and CSL's purchase of Vifor Pharma. The conclusion underscores Switzerland's pivotal role as an innovation hub...